Would you consider using OncoType Dx testing in a patient with breast cancer if nodal evaluation is not performed?
No sentinel lymph node biopsy was performed
Answer from: Medical Oncologist at Academic Institution
In women who are 65 and older who have clinically negative axilla, there are less node assessments done with BCS, given data showing they do not add very much. If the patient is otherwise a candidate for adjuvant chemotherapy, I do check a genomic expression profile, either OncotypeDX or MammaPrint....
Comments
Medical Oncologist at The University of Texas MD Anderson Cancer Center I agree. If a patient has a clinically lymph node ...
I agree. If a patient has a clinically lymph node ...